Lifecore Biomedical (NASDAQ:LFCR) has announced the appointments of Thomas Guldager as vice president of operations and Jackie Klecker as executive vice president of quality development services.
Mr. Guldager brings extensive expertise from the pharmaceutical industry and CDMO sector to Lifecore, while Ms. Klecker’s leadership and strong regulatory compliance experience enhance the company’s newly established quality role.
“As we continue to reshape Lifecore to best position the company to successfully execute on our ambitious growth strategy, we are incredibly fortunate to have two individuals as talented and experienced as Thomas and Jackie overseeing operations and quality. This organizational change strategically bifurcates the operations and quality functions, representing a natural evolution for Lifecore as we embark on our next phase of growth,” said Paul Josephs, president and chief executive officer of Lifecore.
“With our capacity more than doubling through the recent installation of our new 5-head isolator filler, we believe it is essential that we dedicate sufficient focus and resources to our operations. Thomas’ recent leadership at a site that performed fermentation as well as fill/finish activities aligns well with Lifecore’s service offering. I’m confident that having a leader dedicated solely to our operations will help drive meaningful process efficiencies, strengthening our productivity,” he added.
